Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
2023 Standout
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of WM Mulleners being referenced
Noncompliance May Render Migraine Prophylaxis Useless, But Once-Daily Regimens Are Better
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| WM Mulleners | 452 | 163 | 152 | 9 | 536 | |
| EP Chronicle | 407 | 159 | 135 | 8 | 465 | |
| Giuseppe Capocchi | 182 | 226 | 79 | 19 | 553 | |
| Michael Eller | 263 | 92 | 133 | 18 | 495 | |
| PS Sándor | 463 | 162 | 230 | 17 | 539 | |
| J Schoenen | 424 | 210 | 213 | 12 | 478 | |
| Lise Lykke Thomsen | 467 | 98 | 270 | 13 | 594 | |
| Claudia Serpino | 360 | 84 | 124 | 21 | 542 | |
| Mihály Aradi | 167 | 53 | 124 | 23 | 486 | |
| Stefano Caproni | 369 | 61 | 198 | 25 | 497 | |
| Enrico B Arkink | 420 | 102 | 227 | 15 | 508 |
All Works
Loading papers...